Mahinay, Joella Mae S.

HRN: 18-62-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/19/2023
IVT
1.5g
IVT Now ANST Then Q8
G2P1 (1000) 42 2/7 Weeks AOG By LMP; T/C Meconium Stained Amniotic Fluid Via UTZ
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: